作者：
Karolina,Åkesson [1]
;
Susanne,Pettersson [2]
;
Sara,Ståhl [3]
;
Izabella,Surowiec [4]
;
Mattias,Hedenström [5]
;
Susanna,Eketjäll [5]
;
Johan,Trygg [6]
;
Per-Johan,Jakobsson [5]
;
Iva,Gunnarsson [1]
;
Elisabet,Svenungsson [1]
;
Helena,Idborg [1]
作者单位：
Rheumatology Unit, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
[1]
Theme Inflammation and Infection, Karolinska University Hospital, Stockholm, Sweden.
[2]
Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.
[3]
Personalized Healthcare and Biomarkers Laboratories, Innovative Medicines, Science for Life Laboratory, Translational Science Centre, AstraZeneca, Stockholm, Sweden.
[4]
Department of Chemistry, Computational Life Science Cluster, Umeå University, Umeå, Sweden.
[5]
Cardiovascular and Metabolic Diseases, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Integrated Cardio Metabolic Centre (ICMC), Karolinska Institutet, Huddinge, Sweden.
[6]
DOI
10.1136/lupus-2017-000254
PMID
29868176
发布时间
2024-03-18
换一批
换一批
